Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A triple-RBD-based mucosal vaccine provides broad protection against SARS-CoV-2 variants of concern
Jingyi Yang, Meiqin Liu, Lin Liu, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 11, pp. 1279-1289
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine
Lorenzo Azzi, Daniela Dalla Gasperina, Giovanni Veronesi, et al.
EBioMedicine (2023) Vol. 88, pp. 104435-104435
Open Access | Times Cited: 28
A Nanoparticle Vaccine Displaying Conserved Epitopes of the Preexisting Neutralizing Antibody Confers Broad Protection against SARS-CoV-2 Variants
Xuefan Wu, Wei Li, Heng Rong, et al.
ACS Nano (2024) Vol. 18, Iss. 27, pp. 17749-17763
Closed Access | Times Cited: 7
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 16
An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters
Kairat Tabynov, Maxim Solomadin, Nurkeldi Turebekov, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1
Xian Li, Mengxin Xu, Jingyi Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
SARS-CoV-2 spike protein in infectivity
Alaa Muayad Altaie, Rania Hamdy, Mohamed I. Husseiny, et al.
Elsevier eBooks (2025), pp. 21-56
Closed Access
Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
Ming Zhou, Haihua Xiao, Xinyi Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Deimmunization of flagellin adjuvant for clinical application
Joon Haeng Rhee, Koemchhoy Khim, Sao Puth, et al.
Current Opinion in Virology (2023) Vol. 60, pp. 101330-101330
Open Access | Times Cited: 14
Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern
Callum M. Ives, Linh Nguyen, Carl A. Fogarty, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 4
The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination
Jingyi Yang, Meiqin Liu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Mucosal vaccine development for respiratory viral infections
Yifan Lin, Zhenxiang Hu, Yang–Xin Fu, et al.
hLife (2023) Vol. 2, Iss. 2, pp. 50-63
Open Access | Times Cited: 8
Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines
Xuanxuan Zhang, Jialu Zhang, Si Chen, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 362-370
Open Access | Times Cited: 2
Enhanced TLR5-dependent migration and activation of antigen-loaded airway dendritic cells by flagellin
Xu Li, Yuan Cao, Man Mou, et al.
Journal of Leukocyte Biology (2023) Vol. 113, Iss. 6, pp. 567-576
Closed Access | Times Cited: 6
Does the SARS-CoV-2 Spike Receptor-Binding Domain Hamper the Amyloid Transformation of Alpha-Synuclein after All?
Yulia Yu. Stroylova, Anastasiia V. Konstantinova, Viktor S. Stroylov, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 498-498
Open Access | Times Cited: 5
Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants
Sumin Han, P Lee, Hyo‐Jick Choi
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2114-2114
Open Access | Times Cited: 5
The Effect of Select SARS-CoV-2 N-Linked Glycan and Variant of Concern Spike Protein Mutations on C-Type Lectin-Receptor-Mediated Infection
Arjan Bains, Wenyan Guan, Patricia J. LiWang
Viruses (2023) Vol. 15, Iss. 9, pp. 1901-1901
Open Access | Times Cited: 5
Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development
Xinghang Li, Fengyuan Zeng, Rong Yue, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 120-120
Open Access | Times Cited: 1
The identification and characterization of novel and improved antigens for next-generation pertussis vaccines
Gage M. Pyles
(2024)
Open Access | Times Cited: 1
tANCHOR fast and cost-effective cell-based immunization approach with focus on the receptor-binding domain of SARS-CoV-2
Hubert S. Bernauer, Anja Schlör, Josef Maier, et al.
Biology Methods and Protocols (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 3
The 2 nd China Vaccinology Integrated Innovation & Teaching Development Conference: Promoting the construction of vaccinology discipline system
Yingqi Chen, Yuelong Shu, Hui Zheng, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
#GotGlycans: Role of N343 Glycosylation on the SARS-CoV-2 S RBD Structure and Co-Receptor Binding Across Variants of Concern
Callum M. Ives, Linh Nguyen, Carl A. Fogarty, et al.
(2024)
Open Access
#GotGlycans: Role of N343 Glycosylation on the SARS-CoV-2 S RBD Structure and Co-Receptor Binding Across Variants of Concern
Callum M. Ives, Linh Nguyen, Carl A. Fogarty, et al.
(2024)
Open Access
Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern
Callum M. Ives, Linh Nguyen, Carl A. Fogarty, et al.
eLife (2024) Vol. 13
Open Access
Replication-deficient sendai virus expressing human norovirus capsid protein elicits robust NoV-specific antibody and T-cell responses in mice
Yazdan Samieipour, Marian Wiegand, Elena M. Willner, et al.
Microbes and Infection (2024), pp. 105412-105412
Open Access
COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database
Hiroka Nakao, Takenao Koseki, Koki Kato, et al.
Journal of Pharmacy & Pharmaceutical Sciences (2023) Vol. 26
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top